Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.
Daridorexant will help treat insomnia.